UNH PE Ratio & Valuation,Is UNH Overvalued

UNH Relative Valuation

UNH's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, UNH is overvalued; if below, it's undervalued.

Historical Valuation

UnitedHealth Group Inc (UNH) is now in the Fair zone, suggesting that its current forward PE ratio of 19.92 is considered Fairly compared with the five-year average of 20.58. The fair price of UnitedHealth Group Inc (UNH) is between 305.91 to 396.88 according to relative valuation methord.

Relative Value

Fair Zone

305.91-396.88

Current Price：348.97

Fair

19.92

13.46

EV/EBITDA

UnitedHealth Group Inc. (UNH) has a current EV/EBITDA of 13.46. The 5-year average EV/EBITDA is 14.43. The thresholds are as follows: Strongly Undervalued below 10.63, Undervalued between 10.63 and 12.53, Fairly Valued between 16.33 and 12.53, Overvalued between 16.33 and 18.22, and Strongly Overvalued above 18.22. The current Forward EV/EBITDA of 13.46 falls within the Historic Trend Line -Fairly Valued range.

15.94

EV/EBIT

UnitedHealth Group Inc. (UNH) has a current EV/EBIT of 15.94. The 5-year average EV/EBIT is 16.30. The thresholds are as follows: Strongly Undervalued below 11.65, Undervalued between 11.65 and 13.98, Fairly Valued between 18.63 and 13.98, Overvalued between 18.63 and 20.95, and Strongly Overvalued above 20.95. The current Forward EV/EBIT of 15.94 falls within the Historic Trend Line -Fairly Valued range.

0.67

UnitedHealth Group Inc. (UNH) has a current PS of 0.67. The 5-year average PS is 1.18. The thresholds are as follows: Strongly Undervalued below 0.68, Undervalued between 0.68 and 0.93, Fairly Valued between 1.43 and 0.93, Overvalued between 1.43 and 1.68, and Strongly Overvalued above 1.68. The current Forward PS of 0.67 falls within the Strongly Undervalued range.

14.55

P/OCF

UnitedHealth Group Inc. (UNH) has a current P/OCF of 14.55. The 5-year average P/OCF is 17.66. The thresholds are as follows: Strongly Undervalued below 8.49, Undervalued between 8.49 and 13.08, Fairly Valued between 22.25 and 13.08, Overvalued between 22.25 and 26.83, and Strongly Overvalued above 26.83. The current Forward P/OCF of 14.55 falls within the Historic Trend Line -Fairly Valued range.

15.86

P/FCF

UnitedHealth Group Inc. (UNH) has a current P/FCF of 15.86. The 5-year average P/FCF is 18.02. The thresholds are as follows: Strongly Undervalued below 11.59, Undervalued between 11.59 and 14.80, Fairly Valued between 21.24 and 14.80, Overvalued between 21.24 and 24.46, and Strongly Overvalued above 24.46. The current Forward P/FCF of 15.86 falls within the Historic Trend Line -Fairly Valued range.

UnitedHealth Group Inc (UNH) has a current Price-to-Book (P/B) ratio of 3.18. Compared to its 3-year average P/B ratio of 4.93 , the current P/B ratio is approximately -35.47% higher. Relative to its 5-year average P/B ratio of 5.39, the current P/B ratio is about -41.00% higher. UnitedHealth Group Inc (UNH) has a Forward Free Cash Flow (FCF) yield of approximately 5.70%. Compared to its 3-year average FCF yield of 5.42%, the current FCF yield is approximately 5.23% lower. Relative to its 5-year average FCF yield of 5.32% , the current FCF yield is about 7.23% lower.

3.18

P/B

Median3y

4.93

Median5y

5.39

5.70

FCF Yield

Median3y

5.42

Median5y

5.32

Competitors Valuation Multiple

The average P/S ratio for UNH's competitors is 0.31, providing a benchmark for relative valuation. UnitedHealth Group Inc Corp (UNH) exhibits a P/S ratio of 0.67, which is 117.27% above the industry average. Given its robust revenue growth of 12.24%, this premium appears unsustainable.

P/S

P/E

EV/EBITDA

EV/EBIT

Revenue Growth

Market Cap

Performance Decomposition

Market capitalization of UNH decreased by 35.67% over the past 1 year. The primary factor behind the change was an increase in P/E Change from 15.11 to 17.51.

The secondary factor is the Revenue Growth, contributed 12.24%to the performance.

Overall, the performance of UNH in the past 1 year is driven by P/E Change. Which is more unsustainable.

12.24%

100.82B → 113.16B

Revenue Growth

-63.77%

6.21 → 2.25

Margin Expansion

15.86%

15.11 → 17.51

P/E Change

-35.67%

542.49 → 348.97

Mkt Cap Growth

People Also Watch

Frequently Asked Questions

Is UnitedHealth Group Inc (UNH) currently overvalued or undervalued?

What is UnitedHealth Group Inc (UNH) fair value?

UNH's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average , adjusted by weights. The fair price of UnitedHealth Group Inc (UNH) is between 305.91 to 396.88 according to relative valuation methord.

How does UNH's valuation metrics compare to the industry average?

What is the current P/B ratio for UnitedHealth Group Inc (UNH) as of Jan 07 2026?

As of Jan 07 2026, UnitedHealth Group Inc (UNH) has a P/B ratio of 3.18. This indicates that the market values UNH at 3.18 times its book value.

What is the current FCF Yield for UnitedHealth Group Inc (UNH) as of Jan 07 2026?

As of Jan 07 2026, UnitedHealth Group Inc (UNH) has a FCF Yield of 5.70%. This means that for every dollar of UnitedHealth Group Inc’s market capitalization, the company generates 5.70 cents in free cash flow.

What is the current Forward P/E ratio for UnitedHealth Group Inc (UNH) as of Jan 07 2026?

As of Jan 07 2026, UnitedHealth Group Inc (UNH) has a Forward P/E ratio of 19.92. This means the market is willing to pay $19.92 for every dollar of UnitedHealth Group Inc’s expected earnings over the next 12 months.

What is the current Forward P/S ratio for UnitedHealth Group Inc (UNH) as of Jan 07 2026?

As of Jan 07 2026, UnitedHealth Group Inc (UNH) has a Forward P/S ratio of 0.67. This means the market is valuing UNH at $0.67 for every dollar of expected revenue over the next 12 months.

UNH Valuation

Overview

Forecast

Valuation

Earnings